Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:36 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2617–2640 of 7,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: B-cell Acute Lymphoblastic Leukemia, Obesity
Interventions: IDEAL2 Intervention; Behavioral
Lead sponsor: Etan Orgel; Other
Eligibility: 7 Years to 25 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 16
States / cities: Los Angeles, California • Orange, California • San Francisco, California + 13 more

Conditions: Fibromyalgia
Interventions: Erenumab, Saline; Drug
Lead sponsor: United States Naval Medical Center, Portsmouth; Federal
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Portsmouth, Virginia

Conditions: Prostate Cancer
Interventions: Lifestyle intervention; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Opioid Use, Surgery
Interventions: Educational Shared-Decision Making Tool; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 89 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Cervical Carcinoma, Human Papillomavirus Infection
Interventions: Disease Screening, Educational Intervention, Informational Intervention, Laboratory Biomarker Analysis, Survey Administration; Procedure · Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Syphilis, Congenital
Interventions: Benzathine Penicillin, Amoxicillin; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 0 Days to 30 Days
Enrollment: 374 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 11
States / cities: Birmingham, Alabama • Mobile, Alabama • Orange, California + 8 more

Conditions: Rheumatoid Arthritis (RA)
Interventions: Vectra; Diagnostic Test
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 30
States / cities: La Mesa, California • Murrieta, California • Orange, California + 27 more

Conditions: Congenital Syphilis
Interventions: Congenital Syphilis Intervention Group; Behavioral
Lead sponsor: Tulane University School of Public Health and Tropical Medicine; Other
Eligibility: 13 Years and older · Female only
Enrollment: 60,386 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Covid19, Physical Disability
Interventions: heat therapy, exercise training; Behavioral
Lead sponsor: University of Massachusetts, Amherst; Other
Eligibility: 55 Years to 85 Years
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Amherst, Massachusetts

Conditions: Anesthesia, Tubal Ligation
Interventions: Spinal Anesthesia, General Anesthesia; Procedure
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Solid Tumors
Interventions: Asprin, Loratadine, Acetaminophen Avoidance, THC Avoidance; Drug · Behavioral
Lead sponsor: Val Adams; Other
Eligibility: 18 Years to 99 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Tricuspid Valve Insufficiency, Right Heart Failure, Heart Failure
Interventions: Tricuspid valve repair or replacement, Medical management of tricuspid regurgitation; Procedure · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Venous Leg Ulcer, Venous Leg, Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Diabetic, Ulcer Foot, Leg Ulcer, Ulcer Venous, Ulcer
Interventions: ACApatch™, caregraFT™, Standard of Care; Other
Lead sponsor: Tiger Biosciences, LLC.; Industry
Eligibility: 21 Years and older
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Monroeville, Pennsylvania

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Sepsis
Interventions: Glutamine, Placebo; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 72 Hours
Enrollment: 1,433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2001
U.S. locations: 15
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 12 more

Conditions: Human Immunodeficiency Virus
Interventions: Anti-Retroviral Treatment and Access to Services (ARTAS); Other
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older
Enrollment: 1,893 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Hartford, Connecticut • Boston, Massachusetts • Philadelphia, Pennsylvania

Conditions: Nausea and Vomiting, Chemotherapy-Induced
Interventions: Casopitant, Dexamethasone, Placebo, Ondansetron; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 710 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 23
States / cities: Hot Springs, Arkansas • Corona, California • Fountain Valley, California + 19 more

Conditions: Ostomy
Interventions: Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Inguinal Hernia
Interventions: Urinary Catheter; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 491 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Opioid Withdrawal, Pain, Craving
Interventions: Active BRIDGE device placement, Inactive BRIDGE device placement; Device
Lead sponsor: BrightView LLC; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Cincinnati, Ohio

Conditions: Cardiomyopathy, Heart Failure, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions: Best Practice, Laboratory Biomarker Analysis, Mesenchymal Stem Cell Transplantation; Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetes Mellitus
Interventions: Livongo Health System, iHealth Glucose Meter; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Refractory Ascites
Interventions: Study - Transjugular Intrahepatic Portosystemic Shunt (TIPS), Control - Transjugular Intrahepatic Portosystemic Shunt (TIPS); Procedure
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Carcinoma, Small Cell Lung
Interventions: RRx-001 + eLOOP Device, Cisplatin/carboplatin plus etoposide; Drug
Lead sponsor: EpicentRx, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 292 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Tampa, Florida • Westwood, Kansas

Conditions: Conflict, Decisional Conflict
Interventions: mychoice; Behavioral
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 257 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 5
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Investigational Use of Erenumab for the Treatment of Fibromyalgia Pain

Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8

Shared Decision-Making Tool for Opioid Prescribing After Ambulatory Hand Surgery in Veterans

HPV Self-Test Intervention in Ohio Appalachia

Congenital Syphilis Treatment Trial (CONSISTENT) in Neonates

The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

Preventing Congenital Syphilis

Physical Rehabilitation of COVID-19 Survivors by Heat Therapy

Comparative Analysis of Spinal Anesthesia Versus General Anesthesia for vNOTES

Optimizing Ancillary Therapies With Immune Checkpoint Inhibitors for Solid Tumors (OAT ICI)

Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants

Cooperative Re-Engagement Controlled Trial (CoRECT)

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Conducting Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up for Post-discharge Ostomy Patients to Reduce Hospital Readmission

Urinary Retention After Laparoscopic Inguinal Hernia Repair: Comparing the Use of the Intraoperative Urinary Catheter

BRIDGE Device for Treatment of Opioid Withdrawal

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

Study to Understand Gaining Access to Blood Glucose Records

Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)

A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer

Mychoice: Testing an Interactive mHealth Tool